QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||
(Address of principal executive offices) | (Zip Code) | ||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
☒ | Accelerated filer | ☐ | ||||
Non-accelerated filer | ☐ | Smaller reporting company | ||||
Emerging growth company |
PART I. FINANCIAL INFORMATION | |
Page | |
Consolidated Statements of Financial Condition (Unaudited) ......................................................................................................... | |
Consolidated Statements of Earnings (Unaudited) ............................................................................................................................ | |
Consolidated Statements of Comprehensive Income (Unaudited) .................................................................................................. | |
Consolidated Statements of Changes in Equity (Unaudited) ............................................................................................................ | |
Consolidated Statements of Cash Flows (Unaudited) ....................................................................................................................... | |
Notes to Consolidated Financial Statements (Unaudited) ................................................................................................................ | |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations ............................................... | |
Item 3. Quantitative and Qualitative Disclosures About Market Risk .................................................................................................... | |
Item 4. Controls and Procedures .................................................................................................................................................................. | |
PART II. OTHER INFORMATION | |
Item 1. Legal Proceedings ............................................................................................................................................................................. | |
Item 1A. Risk Factors ..................................................................................................................................................................................... | |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds .................................................................................................. | |
Item 5. Other Information .............................................................................................................................................................................. | |
Item 6. Exhibits ................................................................................................................................................................................................ | |
2 | Jefferies Financial Group Inc. |
Consolidated Statements of Financial Condition (Unaudited) | ||
$ in thousands, except share and per share amounts | August 31, 2025 | November 30, 2024 |
Assets | ||
Cash and cash equivalents ............................................................................................................................................................... | $ | $ |
Cash and securities segregated and on deposit for regulatory purposes or deposited with clearing and depository organizations (includes $ | ||
Financial instruments owned, at fair value (includes securities pledged of $ | ||
Investments in and loans to related parties ................................................................................................................................... | ||
Securities borrowed ........................................................................................................................................................................... | ||
Securities purchased under agreements to resell ........................................................................................................................ | ||
Securities received as collateral, at fair value ................................................................................................................................ | ||
Receivables: | ||
Brokers, dealers and clearing organizations ............................................................................................................................... | ||
Customers ........................................................................................................................................................................................ | ||
Fees, interest and other .................................................................................................................................................................. | ||
Premises and equipment .................................................................................................................................................................. | ||
Goodwill ............................................................................................................................................................................................... | ||
Assets held for sale ........................................................................................................................................................................... | ||
Other assets (includes assets pledged of $ | ||
Total assets ........................................................................................................................................................................................ | $ | $ |
Liabilities and Equity | ||
Short-term borrowings ...................................................................................................................................................................... | $ | $ |
Financial instruments sold, not yet purchased, at fair value ....................................................................................................... | ||
Securities loaned ................................................................................................................................................................................ | ||
Securities sold under agreements to repurchase ......................................................................................................................... | ||
Other secured financings (includes $ | ||
Obligation to return securities received as collateral, at fair value ............................................................................................. | ||
Payables: | ||
Brokers, dealers and clearing organizations ............................................................................................................................... | ||
Customers ........................................................................................................................................................................................ | ||
Lease liabilities ................................................................................................................................................................................... | ||
Accrued expenses and other liabilities ........................................................................................................................................... | ||
Long-term debt (includes $ | ||
Total liabilities .................................................................................................................................................................................... | ||
Mezzanine Equity | ||
Redeemable noncontrolling interests ............................................................................................................................................. | ||
Equity | ||
Preferred shares, par value of $ liquidation preference of $ | ||
Common shares, par value $ and outstanding, after deducting | ||
Non-voting common shares, par value $ outstanding .................................................................................................................................................................................... | ||
Additional paid-in capital .................................................................................................................................................................. | ||
Accumulated other comprehensive loss ........................................................................................................................................ | ( | ( |
Retained earnings .............................................................................................................................................................................. | ||
Total Jefferies Financial Group Inc. shareholders' equity .......................................................................................................... | ||
Noncontrolling interests ................................................................................................................................................................... | ||
Total equity ......................................................................................................................................................................................... | ||
Total liabilities and equity ................................................................................................................................................................ | $ | $ |
August 2025 Form 10-Q | 3 |
Three Months Ended August 31, | Nine Months Ended August 31, | ||||||
$ in thousands, except per share amounts | 2025 | 2024 | 2025 | 2024 | |||
Revenues | |||||||
Investment banking ............................................................................................... | $ | $ | $ | $ | |||
Principal transactions ............................................................................................ | |||||||
Commissions and other fees ............................................................................... | |||||||
Asset management fees and revenues .............................................................. | |||||||
Interest ..................................................................................................................... | |||||||
Other ......................................................................................................................... | |||||||
Total revenues ........................................................................................................ | |||||||
Interest expense ..................................................................................................... | |||||||
Net revenues ........................................................................................................... | |||||||
Non-interest expenses | |||||||
Compensation and benefits ................................................................................. | |||||||
Brokerage and clearing fees ................................................................................. | |||||||
Underwriting costs ................................................................................................. | |||||||
Technology and communications ....................................................................... | |||||||
Occupancy and equipment rental ........................................................................ | |||||||
Business development .......................................................................................... | |||||||
Professional services ............................................................................................ | |||||||
Depreciation and amortization ............................................................................. | |||||||
Cost of sales ........................................................................................................... | |||||||
Other expenses ....................................................................................................... | |||||||
Total non-interest expenses ................................................................................ | |||||||
Earnings from continuing operations before income taxes ............................ | |||||||
Income tax expense ............................................................................................... | |||||||
Net earnings from continuing operations ........................................................... | |||||||
Net earnings (losses) from discontinued operations (including gain on disposal of $ $ | ( | ||||||
Net earnings ........................................................................................................... | |||||||
Net losses attributable to noncontrolling interests ........................................... | ( | ( | ( | ( | |||
Preferred stock dividends ..................................................................................... | |||||||
Net earnings attributable to common shareholders ........................................ | $ | $ | $ | $ | |||
Earnings per common share | |||||||
Basic from continuing operations ....................................................................... | $ | $ | $ | $ | |||
Diluted from continuing operations ..................................................................... | |||||||
Basic ......................................................................................................................... | |||||||
Diluted ...................................................................................................................... | |||||||
Weighted-average common shares outstanding ............................................. | |||||||
Basic ......................................................................................................................... | |||||||
Diluted ...................................................................................................................... | |||||||
4 | Jefferies Financial Group Inc. |
Three Months Ended August 31, | Nine Months Ended August 31, | ||||||
$ in thousands | 2025 | 2024 | 2025 | 2024 | |||
Net earnings ................................................................................................................... | $ | $ | $ | $ | |||
Other comprehensive income (loss), net of tax: | |||||||
Currency translation adjustments and other (1) ...................................................... | |||||||
Changes in fair value related to instrument-specific credit risk (2) ...................... | ( | ||||||
Unrealized gains on available-for-sale-securities ................................................... | |||||||
Total other comprehensive income (loss), net of tax (3) ....................................... | ( | ||||||
Comprehensive income ................................................................................................ | |||||||
Net losses attributable to noncontrolling interests .................................................. | ( | ( | ( | ( | |||
Preferred stock dividends ............................................................................................ | |||||||
Comprehensive income attributable to common shareholders ............................ | $ | $ | $ | $ | |||
August 2025 Form 10-Q | 5 |
Three Months Ended August 31, | Nine Months Ended August 31, | ||||||
$ in thousands, except par value and per share amounts | 2025 | 2024 | 2025 | 2024 | |||
Preferred shares $1 par value | |||||||
Balance, beginning of period ............................................................................. | $ | $ | $ | $ | |||
Conversion of common shares to preferred shares ................................... | |||||||
Balance, end of period ....................................................................................... | $ | $ | $ | $ | |||
Common shares $1 par value | |||||||
Balance, beginning of period ............................................................................. | $ | $ | $ | $ | |||
Purchase of common shares for treasury ................................................... | ( | ( | ( | ( | |||
Conversion of common shares to preferred shares ................................... | ( | ( | |||||
Other .................................................................................................................. | |||||||
Balance, end of period ....................................................................................... | $ | $ | $ | $ | |||
Additional paid-in capital | |||||||
Balance, beginning of period ............................................................................. | $ | $ | $ | $ | |||
Share-based compensation expense ............................................................ | |||||||
Purchase of common shares for treasury ................................................... | ( | ( | ( | ( | |||
Dividend equivalents ....................................................................................... | |||||||
Conversion of common shares to preferred shares ................................... | |||||||
Change in equity interest related to consolidated subsidiaries ................ | ( | ( | |||||
Other .................................................................................................................. | |||||||
Balance, end of period ....................................................................................... | $ | $ | $ | $ | |||
Accumulated other comprehensive loss, net of tax | |||||||
Balance, beginning of period ............................................................................. | $( | $( | $( | $( | |||
Other comprehensive income (loss), net of taxes ...................................... | ( | ||||||
Balance, end of period ....................................................................................... | $( | $( | $( | $( | |||
Retained earnings | |||||||
Balance, beginning of period ............................................................................. | $ | $ | $ | $ | |||
Net earnings attributable to Jefferies Financial Group Inc. ....................... | |||||||
Dividends - common shares ($ | ( | ( | ( | ( | |||
Dividends - preferred shares .......................................................................... | ( | ( | ( | ( | |||
Cumulative effect of change in accounting principle for current expected credit losses, net of tax ............................................................. | ( | ||||||
Other .................................................................................................................. | ( | ||||||
Balance, end of period ....................................................................................... | $ | $ | $ | $ | |||
Total Jefferies Financial Group Inc. shareholders' equity ........................... | $ | $ | $ | $ | |||
Noncontrolling interests | |||||||
Balance, beginning of period ............................................................................. | $ | $ | $ | $ | |||
Net losses attributable to noncontrolling interests .................................... | ( | ( | ( | ( | |||
Contributions .................................................................................................... | |||||||
Distributions ..................................................................................................... | ( | ( | ( | ( | |||
Change in equity interest related to consolidated subsidiaries ................ | |||||||
Other .................................................................................................................. | ( | ( | ( | ||||
Balance, end of period ....................................................................................... | $ | $ | $ | $ | |||
Total equity .......................................................................................................... | $ | $ | $ | $ | |||
6 | Jefferies Financial Group Inc. |
Nine Months Ended August 31, | ||
$ in thousands | 2025 | 2024 |
Cash flows from operating activities: | ||
Net earnings ...................................................................................................................................................................................... | $ | $ |
Adjustments to reconcile net earnings to net cash used in operating activities: | ||
Depreciation and amortization .................................................................................................................................................... | ||
Share-based compensation ......................................................................................................................................................... | ||
Net bad debt expense ................................................................................................................................................................... | ||
Income on investments in and loans to related parties ........................................................................................................... | ( | ( |
Distributions received on investments in related parties ........................................................................................................ | ||
Gain on sale of subsidiaries and investments in related parties ............................................................................................ | ( | |
Loss on assets held for sale ........................................................................................................................................................ | ||
Other adjustments ......................................................................................................................................................................... | ||
Net change in assets and liabilities: | ||
Receivables: | ||
Brokers, dealers and clearing organizations .......................................................................................................................... | ( | ( |
Customers ................................................................................................................................................................................... | ( | ( |
Fees, interest and other ............................................................................................................................................................. | ( | ( |
Securities borrowed ...................................................................................................................................................................... | ( | |
Financial instruments owned ....................................................................................................................................................... | ( | ( |
Securities purchased under agreements to resell .................................................................................................................... | ( | ( |
Other assets ................................................................................................................................................................................... | ( | ( |
Payables: | ||
Brokers, dealers and clearing organizations .......................................................................................................................... | ( | |
Customers ................................................................................................................................................................................... | ( | |
Securities loaned ........................................................................................................................................................................... | ( | |
Financial instruments sold, not yet purchased ......................................................................................................................... | ||
Securities sold under agreements to repurchase ..................................................................................................................... | ( | ( |
Lease liabilities .............................................................................................................................................................................. | ( | ( |
Accrued expenses and other liabilities ...................................................................................................................................... | ( | |
Net cash used in operating activities from continuing operations ......................................................................................... | ( | ( |
Net cash used in operating activities from discontinued operations ..................................................................................... | ( | |
Cash flows from investing activities: | ||
Contributions to investments in and loans to related parties ................................................................................................. | ( | ( |
Capital distributions from investments and repayments of loans from related parties ..................................................... | ||
Originations and purchases of automobile loans, notes and other receivables .................................................................. | ( | |
Principal collections of automobile loans, notes and other receivables ............................................................................... | ||
Net payments on premises and equipment .............................................................................................................................. | ( | ( |
Proceeds from assets held for sale ............................................................................................................................................ | ||
Proceeds from sales of subsidiary and investment in related parties, net of cash of operations sold ........................... | ||
Net cash (used in) provided by investing activities from continuing operations ................................................................. | ( | |
August 2025 Form 10-Q | 7 |
Nine Months Ended August 31, | ||
$ in thousands | 2025 | 2024 |
Cash flows from financing activities: | ||
Proceeds from short-term borrowings ....................................................................................................................................... | $ | $ |
Payments on short-term borrowings .......................................................................................................................................... | ( | ( |
Proceeds from issuance of long-term debt, net of issuance costs ....................................................................................... | ||
Repayment of long-term debt ...................................................................................................................................................... | ( | ( |
Proceeds from conversion of common to preferred shares ................................................................................................... | ||
Purchase of common shares for treasury ................................................................................................................................. | ( | ( |
Dividends paid to common and preferred shareholders ......................................................................................................... | ( | ( |
Net proceeds from other secured financings ........................................................................................................................... | ||
Net change in bank overdrafts .................................................................................................................................................... | ( | ( |
Proceeds from contributions of noncontrolling interests ....................................................................................................... | ||
Payments on distributions to noncontrolling interests ............................................................................................................ | ( | ( |
Other ................................................................................................................................................................................................ | ||
Net cash provided by financing activities from continuing operations .................................................................................. | ||
Net cash used in financing activities from discontinued operations ...................................................................................... | ( | |
Effect of exchange rate changes on cash, cash equivalents, and restricted cash ............................................................... | ||
Change in cash, cash equivalents, and restricted cash reclassified from (to) assets held for sale .................................... | ( | |
Net (decrease) increase in cash, cash equivalents, and restricted cash ................................................................................. | ( | |
Cash, cash equivalents, and restricted cash at beginning of period ........................................................................................ | ||
Cash, cash equivalents, and restricted cash at end of period .................................................................................................. | $ | $ |
Supplemental disclosures of cash flow information: | ||
Cash paid during the period for: | ||
Interest ............................................................................................................................................................................................ | $ | $ |
Income taxes, net (1) .................................................................................................................................................................... | ||
August 31, | November 30, | |
$ in thousands | 2025 | 2024 |
Cash and cash equivalents ........................................................................................................................................... | $ | $ |
Cash on deposit for regulatory purposes with clearing and depository organizations ....................................... | ||
Total cash, cash equivalents and restricted cash .................................................................................................... | $ | $ |
8 | Jefferies Financial Group Inc. |
Page | |
Note 1. Organization and Basis of Presentation ...................................................................................................................................................................... | |
Note 2. Summary of Significant Accounting Policies ............................................................................................................................................................. | |
Note 3. Accounting Developments ............................................................................................................................................................................................ | |
Note 4. Business Acquisitions .................................................................................................................................................................................................... | |
Note 5. Assets Held for Sale and Discontinued Operations ................................................................................................................................................... | |
Note 6. Fair Value Disclosures .................................................................................................................................................................................................... | |
Note 7. Derivative Financial Instruments .................................................................................................................................................................................. | |
Note 8. Collateralized Transactions ........................................................................................................................................................................................... | |
Note 9. Securitization Activities ................................................................................................................................................................................................. | |
Note 10. Variable Interest Entities .............................................................................................................................................................................................. | |
Note 11. Investments ................................................................................................................................................................................................................... | |
Note 12. Credit Losses on Financial Assets Measured at Amortized Cost ......................................................................................................................... | |
Note 13. Goodwill and Intangible Assets .................................................................................................................................................................................. | |
Note 14. Revenues from Contracts with Customers ............................................................................................................................................................... | |
Note 15. Compensation Plans .................................................................................................................................................................................................... | |
Note 16. Borrowings ..................................................................................................................................................................................................................... | |
Note 17. Total Equity .................................................................................................................................................................................................................... | |
Note 18. Income Taxes ................................................................................................................................................................................................................ | |
Note 19. Commitments, Contingencies and Guarantees ....................................................................................................................................................... | |
Note 20. Regulatory Requirements ............................................................................................................................................................................................ | |
Note 21. Segment Reporting ....................................................................................................................................................................................................... | |
Note 22. Related Party Transactions ......................................................................................................................................................................................... |
August 2025 Form 10-Q | 9 |
10 | Jefferies Financial Group Inc. |
August 2025 Form 10-Q | 11 |
12 | Jefferies Financial Group Inc. |
August 31, 2025 (1) | |||||
$ in thousands | Level 1 | Level 2 | Level 3 | Counterparty and Cash Collateral Netting (2) | Total |
Assets: | |||||
Financial instruments owned: | |||||
Corporate equity securities .................................................................................. | $ | $ | $ | $— | $ |
Corporate debt securities ..................................................................................... | — | ||||
Collateralized debt obligations and collateralized loan obligations ............... | — | ||||
U.S. government and federal agency securities ................................................ | — | ||||
Municipal securities .............................................................................................. | — | ||||
Sovereign obligations ............................................................................................ | — | ||||
Residential mortgage-backed securities ............................................................ | — | ||||
Commercial mortgage-backed securities .......................................................... | — | ||||
Other asset-backed securities ............................................................................. | — | ||||
Loans and other receivables ................................................................................ | — | ||||
Derivatives .............................................................................................................. | ( | ||||
Investments at fair value ...................................................................................... | — | ||||
Total financial instruments owned, excluding Investments at fair value based on NAV .................................................................................................... | $ | $ | $ | $( | $ |
Securities received as collateral .......................................................................... | $ | $ | $ | $— | $ |
Liabilities: | |||||
Financial instruments sold, not yet purchased: | |||||
Corporate equity securities .................................................................................. | $ | $ | $ | $— | $ |
Corporate debt securities ..................................................................................... | — | ||||
U.S. government and federal agency securities ................................................ | — | ||||
Sovereign obligations ............................................................................................ | — | ||||
Commercial mortgage-backed securities .......................................................... | — | ||||
Loans ....................................................................................................................... | — | ||||
Derivatives .............................................................................................................. | ( | ||||
Total financial instruments sold, not yet purchased ....................................... | $ | $ | $ | $( | $ |
Other secured financings ...................................................................................... | $ | $ | $ | $— | $ |
Obligation to return securities received as collateral ....................................... | — | ||||
Long-term debt ....................................................................................................... | — | ||||
August 2025 Form 10-Q | 13 |
November 30, 2024 (1) | |||||
$ in thousands | Level 1 | Level 2 | Level 3 | Counterparty and Cash Collateral Netting (2) | Total |
Assets: | |||||
Financial instruments owned: | |||||
Corporate equity securities .................................................................................. | $ | $ | $ | $— | $ |
Corporate debt securities ..................................................................................... | — | ||||
Collateralized debt obligations and collateralized loan obligations ............... | — | ||||
U.S. government and federal agency securities ................................................ | — | ||||
Municipal securities .............................................................................................. | — | ||||
Sovereign obligations ............................................................................................ | — | ||||
Residential mortgage-backed securities ............................................................ | — | ||||
Commercial mortgage-backed securities .......................................................... | — | ||||
Other asset-backed securities ............................................................................. | — | ||||
Loans and other receivables ................................................................................ | — | ||||
Derivatives .............................................................................................................. | ( | ||||
Investments at fair value ...................................................................................... | — | ||||
Total financial instruments owned, excluding Investments at fair value based on NAV .................................................................................................... | $ | $ | $ | $( | $ |
Securities segregated and on deposit for regulatory purposes or deposited with clearing and depository organizations ................................ | $ | $ | $ | $— | $ |
Securities received as collateral .......................................................................... | — | ||||
Liabilities: | |||||
Financial instruments sold, not yet purchased: | |||||
Corporate equity securities .................................................................................. | $ | $ | $ | $— | $ |
Corporate debt securities ..................................................................................... | — | ||||
U.S. government and federal agency securities ................................................ | — | ||||
Sovereign obligations ............................................................................................ | — | ||||
Commercial mortgage-backed securities ......................................................... | — | ||||
Loans ....................................................................................................................... | — | ||||
Derivatives .............................................................................................................. | ( | ||||
Total financial instruments sold, not yet purchased ....................................... | $ | $ | $ | $( | $ |
Other secured financings ...................................................................................... | $ | $ | $ | $— | $ |
Obligation to return securities received as collateral ...................................... | — | ||||
Long-term debt ....................................................................................................... | — | ||||
14 | Jefferies Financial Group Inc. |
August 31, 2025 | ||||
$ in thousands | Fair Value (1) | Unfunded Commitments | Redemption Frequency | Redemption Notice Period |
Hedge Funds (2) .............. | $ | $ | Quarterly ( Monthly ( | |
Private Equity Funds (3) .............. | N/R ( | N/R | ||
Credit Funds (4) .............. | Quarterly ( Monthly ( N/R ( | N/R | ||
Real Estate and Other Funds (5) .... | Quarterly ( N/R ( | N/R | ||
Total ...................... | $ | $ | ||
November 30, 2024 | ||||
$ in thousands | Fair Value (1) | Unfunded Commitments | Redemption Frequency | Redemption Notice Period |
Hedge Funds (2) ............ | $ | $ | Quarterly ( Monthly ( | |
Private Equity Funds (3) ............ | N/R ( | N/R | ||
Credit Funds (4) | Quarterly ( Monthly ( N/R ( | N/R | ||
Real Estate and Other Funds (5) . | N/R ( | N/R | ||
Total ................... | $ | $ | ||
August 2025 Form 10-Q | 15 |
Three Months Ended August 31, 2025 | ||||||||||
$ in thousands | Balance at May 31, 2025 | Total gains/ losses (realized and unrealized) (1) | Purchases | Sales | Settlements | Issuances | Net transfers into/ (out of) Level 3 | Balance at August 31, 2025 | For instruments still held at August 31, 2025, changes in unrealized gains (losses) included in: | |
Earnings (1) | Other comprehensive income (loss) (1) | |||||||||
Level 3 assets: | ||||||||||
Financial instruments owned: | ||||||||||
Corporate equity securities .................... | $ | $ | $ | $( | $( | $ | $ | $ | $ | $ |
Corporate debt securities ...................... | ( | ( | ||||||||
CDOs and CLOs ....................................... | ( | ( | ( | ( | ( | |||||
RMBS ........................................................ | ( | |||||||||
CMBS ........................................................ | ||||||||||
Other ABS ................................................. | ( | ( | ( | ( | ( | |||||
Loans and other receivables ................. | ( | ( | ||||||||
Investments at fair value ........................ | ( | ( | ||||||||
Level 3 liabilities: | ||||||||||
Financial instruments sold, not yet purchased: | ||||||||||
Corporate equity securities .................... | $ | $( | $( | $ | $ | $ | $ | $ | $ | $ |
Corporate debt securities ...................... | ( | ( | ( | |||||||
CMBS ........................................................ | ||||||||||
Loans ........................................................ | ( | ( | ||||||||
Net derivatives (2) ................................... | ( | ( | ( | ( | ||||||
Other secured financings ....................... | ( | ( | — | |||||||
Long-term debt ........................................ | ( | ( | ( | ( | ||||||
Nine Months Ended August 31, 2025 | ||||||||||
$ in thousands | Balance at November 30, 2024 | Total gains/ losses (realized and unrealized) (1) | Purchases | Sales | Settlements | Issuances | Net transfers into/ (out of) Level 3 | Balance at August 31, 2025 | For instruments still held at August 31, 2025, changes in unrealized gains (losses) included in: | |
Earnings (1) | Other comprehensive income (loss) (1) | |||||||||
Assets: | ||||||||||
Financial instruments owned: | ||||||||||
Corporate equity securities ................ | $ | $ | $ | $( | $ | $ | $( | $ | $ | $ |
Corporate debt securities ................... | ( | ( | ( | |||||||
CDOs and CLOs ................................... | ( | ( | ( | ( | ( | |||||
Sovereign obligations ......................... | ( | |||||||||
RMBS ..................................................... | ( | |||||||||
CMBS .................................................... | ||||||||||
Other ABS ............................................. | ( | ( | ( | ( | ||||||
Loans and other receivables .............. | ( | ( | ( | |||||||
Investments at fair value .................... | ( | ( | ( | |||||||
Liabilities: | ||||||||||
Financial instruments sold, not yet purchased: | ||||||||||
Corporate equity securities ................ | $ | $( | $( | $ | $ | $ | $ | $ | $ | $ |
Corporate debt securities ................... | ( | ( | ||||||||
CMBS .................................................... | ( | |||||||||
Loans .................................................... | ( | ( | ( | |||||||
Net derivatives (2) ............................... | ( | ( | ( | |||||||
Other secured financings ................... | ( | ( | — | |||||||
Long-term debt .................................... | ( | ( | ( | ( | ||||||
16 | Jefferies Financial Group Inc. |
August 2025 Form 10-Q | 17 |
Three Months Ended August 31, 2024 | ||||||||||
$ in thousands | Balance at May 31, 2024 | Total gains/ losses (realized and unrealized) (1) | Purchases | Sales | Settlements | Issuances | Net transfers into/ (out of) Level 3 | Balance at August 31, 2024 | For instruments still held at August 31, 2024, changes in unrealized gains (losses) included in: | |
Earnings (1) | Other comprehensive income (loss) (1) | |||||||||
Assets: | ||||||||||
Financial instruments owned: | ||||||||||
Corporate equity securities ................. | $ | $ | $ | $( | $( | $ | $ | $ | $ | $ |
Corporate debt securities ................... | ( | ( | ||||||||
CDOs and CLOs .................................... | ( | ( | ( | |||||||
Sovereign obligations .......................... | ||||||||||
RMBS ..................................................... | ( | ( | ||||||||
CMBS ..................................................... | ||||||||||
Other ABS .............................................. | ( | ( | ( | ( | ( | |||||
Loans and other receivables .............. | ( | ( | ( | ( | ||||||
Investments at fair value ..................... | ||||||||||
Liabilities: | ||||||||||
Financial instruments sold, not yet purchased: | ||||||||||
Corporate equity securities ................. | $ | $ | $ | $ | $ | $ | $( | $ | $( | $ |
Corporate debt securities ................... | ( | |||||||||
CMBS ..................................................... | ||||||||||
Loans ..................................................... | ( | |||||||||
Net derivatives (2) ................................ | ( | |||||||||
Other secured financings .................... | — | |||||||||
Long-term debt ..................................... | ( | ( | ||||||||
Nine Months Ended August 31, 2024 | ||||||||||
$ in thousands | Balance at November 30, 2023 | Total gains/ losses (realized and unrealized) (1) | Purchases | Sales | Settlements | Issuances | Net transfers into/ (out of) Level 3 | Balance at August 31, 2024 | For instruments still held at August 31, 2024, changes in unrealized gains (losses) included in: | |
Earnings (1) | Other comprehensive income (loss) (1) | |||||||||
Assets: | ||||||||||
Financial instruments owned: | ||||||||||
Corporate equity securities ................ | $ | $( | $ | $( | $ | $ | $( | $ | $( | $ |
Corporate debt securities ................... | ( | ( | ( | |||||||
CDOs and CLOs ................................... | ( | ( | ( | |||||||
Sovereign obligations ......................... | ( | ( | ||||||||
RMBS ..................................................... | ( | ( | ( | ( | ||||||
CMBS .................................................... | ( | ( | ||||||||
Other ABS ............................................. | ( | ( | ( | ( | ||||||
Loans and other receivables .............. | ( | ( | ( | ( | ||||||
Investments at fair value .................... | ( | ( | ( | ( | ||||||
Liabilities: | ||||||||||
Financial instruments sold, not yet purchased: | ||||||||||
Corporate equity securities | $ | $ | $ | $ | $ | $ | $ | $ | $( | $ |
Corporate debt securities ................... | ( | |||||||||
CMBS .................................................... | ( | ( | ( | |||||||
Loans .................................................... | ( | ( | ( | |||||||
Net derivatives (2) ............................... | ( | ( | ( | |||||||
Other secured financings ................... | ( | ( | ||||||||
Long-term debt .................................... | ( | ( | ( | |||||||
18 | Jefferies Financial Group Inc. |
August 2025 Form 10-Q | 19 |
August 31, 2025 | |||||||
Financial Instruments Owned | Fair Value (in thousands) | Valuation Technique | Significant Unobservable Input(s) | Input / Range | Weighted Average | ||
Corporate equity securities ..................... | $ | ||||||
Non-exchange-traded securities | Market approach | Price | $ | - | $ | $ | |
Volatility Benchmarking | Volatility | - | |||||
Corporate debt securities ........................ | $ | Market approach | Price | $ | - | $ | $ |
Discounted cash flows | Discount rate/yield | - | |||||
CDOs and CLOs .......................................... | $ | Discounted cash flows | Constant prepayment rate | — | |||
Constant default rate | — | ||||||
Loss severity | — | ||||||
Discount rate/yield | - | ||||||
Market approach | Price | $ | - | $ | $ | ||
RMBS ........................................................... | $ | Discounted cash flows | Constant prepayment rate | — | |||
Constant default rate | — | ||||||
Loss severity | — | ||||||
Discount rate/yield | — | ||||||
Other ABS ................................................... | $ | Discounted cash flows | Discount rate/yield | - | |||
Cumulative loss rate | - | ||||||
Duration (years) | - | ||||||
Market approach | Price | $ | - | $ | $ | ||
Scenario analysis | Estimated recovery percentage | — | |||||
Loans and other receivables ................... | $ | Market approach | Price | $ | - | $ | $ |
Scenario analysis | Estimated recovery percentage | - | |||||
Derivatives .................................................. | $ | ||||||
Embedded options | Market approach | Basis points upfront | - | ||||
Equity options | Volatility Benchmarking | Volatility | — | ||||
Investments at fair value .......................... | $ | ||||||
Private equity securities | Market approach | Price | $ | - | $ | $ | |
Discount rate/yield | - | ||||||
Estimated revenue | $ | — | |||||
Financial Instruments Sold, Not Yet Purchased: | |||||||
Loans .......................................................... | $ | Market approach | Price | $ | |||
Derivatives .................................................. | $ | ||||||
Equity options | Volatility benchmarking | Volatility | - | ||||
Embedded options | Market approach | Basis points upfront | - | ||||
Other secured financings ......................... | $ | Scenario analysis | Estimated recovery percentage | - | |||
Market approach | Price | $ | - | $ | $ | ||
Long-term debt .......................................... | $ | ||||||
Structured notes | Market approach | Price | $ | - | $ | $ | |
20 | Jefferies Financial Group Inc. |
November 30, 2024 | |||||||
Financial Instruments Owned | Fair Value (in thousands) | Valuation Technique | Significant Unobservable Input(s) | Input / Range | Weighted Average | ||
Corporate equity securities ..................... | $ | ||||||
Non-exchange-traded securities | Market approach | Price | $ | - | $ | $ | |
Corporate debt securities ........................ | $ | Market approach | Price | $ | - | $ | $ |
CDOs and CLOs .......................................... | $ | Discounted cash flows | Constant prepayment rate | — | |||
Constant default rate | — | ||||||
Loss severity | — | ||||||
Discount rate/yield | - | ||||||
Market approach | Price | $ | - | $ | $ | ||
RMBS ........................................................... | $ | Discounted cash flows | Constant prepayment rate | — | |||
Loss severity | — | ||||||
Discount rate/yield | — | ||||||
Other ABS ................................................... | $ | Discounted cash flows | Discount rate/yield | - | |||
Cumulative loss rate | - | ||||||
Duration (years) | - | ||||||
Market approach | Price | $ | - | $ | $ | ||
Scenario analysis | Estimated recovery percentage | — | |||||
Loans and other receivables ................... | $ | Market approach | Price | $ | - | $ | $ |
Scenario analysis | Estimated recovery percentage | - | |||||
Derivatives .................................................. | $ | ||||||
Embedded options | Market approach | Basis points upfront | — | ||||
Investments at fair value .......................... | $ | ||||||
Private equity securities | Market approach | Price | $ | - | $ | $ | |
Discount rate/yield | — | ||||||
Estimated revenue | $ | — | |||||
Financial Instruments Sold, Not Yet Purchased: | |||||||
Loans .......................................................... | $ | Market approach | Price | $ | - | $ | $ |
Scenario analysis | Estimated recovery percentage | - | |||||
Derivatives .................................................. | $ | ||||||
Equity options | Volatility benchmarking | Volatility | - | ||||
Options | Market approach | Basis points upfront | - | ||||
Other secured financings ......................... | $ | Scenario analysis | Estimated recovery percentage | - | |||
Market approach | Price | $ | — | ||||
Long-term debt .......................................... | $ | ||||||
Structured notes | Market approach | Price | $ | - | $ | $ | |
August 2025 Form 10-Q | 21 |
Three Months Ended August 31, | Nine Months Ended August 31, | |||
$ in thousands | 2025 | 2024 | 2025 | 2024 |
Financial instruments owned: | ||||
Loans and other receivables (1) . | $( | $( | $( | $( |
Other secured financings: | ||||
Other changes in fair value (1) ... | $( | $ | $( | $( |
Long-term debt: | ||||
Changes in instrument-specific credit risk (2) ............................ | $( | $ | $ | $ |
Other changes in fair value (1) ... | ( | ( | ( | ( |
$ in thousands | August 31, 2025 | November 30, 2024 |
Financial instruments owned: | ||
Loans and other receivables (1) ............................... | $ | $ |
Loans and other receivables on nonaccrual status and/or 90 days or greater past due (1) (2) ............................................................... | ||
Long-term debt ........................................................... | ||
Other secured financings ......................................... | ( |
22 | Jefferies Financial Group Inc. |
August 31, 2025 (1) | ||||
Assets | Liabilities | |||
$ in thousands | Fair Value | Number of Contracts (2) | Fair Value | Number of Contracts (2) |
Derivatives designated as accounting hedges: | ||||
Interest rate contracts: | ||||
Cleared OTC ........................................ | $ | $ | ||
Foreign exchange contracts: | ||||
Bilateral OTC ....................................... | ||||
Total derivatives designated as accounting hedges ............................ | ||||
Derivatives not designated as accounting hedges: | ||||
Interest rate contracts: | ||||
Exchange-traded ................................ | ||||
Cleared OTC ........................................ | ||||
Bilateral OTC ....................................... | ||||
Foreign exchange contracts: | ||||
Exchange-traded ................................ | ||||
Bilateral OTC ....................................... | ||||
Equity contracts: | ||||
Exchange-traded ................................ | ||||
Bilateral OTC ....................................... | ||||
Commodity contracts: | ||||
Exchange-traded ................................ | ||||
Bilateral OTC ....................................... | ||||
Credit contracts: | ||||
Cleared OTC ........................................ | ||||
Bilateral OTC ....................................... | ||||
Total derivatives not designated as accounting hedges ....................... | ||||
Total gross derivative assets/ liabilities: | ||||
Exchange-traded ................................ | ||||
Cleared OTC ........................................ | ||||
Bilateral OTC ....................................... | ||||
Amounts offset in our Consolidated Statements of Financial Condition (3): | ||||
Exchange-traded ................................ | ( | ( | ||
Cleared OTC ........................................ | ( | ( | ||
Bilateral OTC ....................................... | ( | ( | ||
Net amounts per Consolidated Statements of Financial Condition (4) ................................. | $ | $ | ||
August 2025 Form 10-Q | 23 |
November 30, 2024 (1) | ||||
Assets | Liabilities | |||
$ in thousands | Fair Value | Number of Contracts (2) | Fair Value | Number of Contracts (2) |
Derivatives designated as accounting hedges: | ||||
Interest rate contracts: | ||||
Cleared OTC ......................................... | $ | $ | ||
Foreign exchange contracts: | ||||
Bilateral OTC ........................................ | ||||
Total derivatives designated as accounting hedges ............................. | ||||
Derivatives not designated as accounting hedges: | ||||
Interest rate contracts: | ||||
Exchange-traded ................................. | ||||
Cleared OTC ......................................... | ||||
Bilateral OTC ........................................ | ||||
Foreign exchange contracts: | ||||
Bilateral OTC ........................................ | ||||
Equity contracts: | ||||
Exchange-traded ................................. | ||||
Bilateral OTC ........................................ | ||||
Commodity contracts: | ||||
Exchange-traded ................................. | ||||
Bilateral OTC ....................................... | ||||
Credit contracts: | ||||
Cleared OTC ......................................... | ||||
Bilateral OTC ........................................ | ||||
Total derivatives not designated as accounting hedges ............................. | ||||
Total gross derivative assets/ liabilities: | ||||
Exchange-traded ................................. | ||||
Cleared OTC ......................................... | ||||
Bilateral OTC ........................................ | ||||
Amounts offset in our Consolidated Statements of Financial Condition (3): | ||||
Exchange-traded ................................. | ( | ( | ||
Cleared OTC ......................................... | ( | ( | ||
Bilateral OTC ........................................ | ( | ( | ||
Net amounts per Consolidated Statements of Financial Condition (4) .................................. | $ | $ | ||
$ in thousands | Three Months Ended August 31, | Nine Months Ended August 31, | ||
Gains (Losses) | 2025 | 2024 | 2025 | 2024 |
Interest rate swaps (1) .................. | $ | $ | $ | $ |
Long-term debt ............................... | ( | ( | ( | ( |
Total ................................................. | $( | $( | $( | $( |
$ in thousands | Three Months Ended August 31, | Nine Months Ended August 31, | ||
Gains (Losses) | 2025 | 2024 | 2025 | 2024 |
Foreign exchange contracts ......... | $( | $( | $( | $( |
Total ................................................. | $( | $( | $( | $( |
$ in thousands | Three Months Ended August 31, | Nine Months Ended August 31, | ||
Gains (Losses) | 2025 | 2024 | 2025 | 2024 |
Interest rate contracts ................... | $ | $ | $( | $ |
Foreign exchange contracts ......... | ( | |||
Equity contracts .............................. | ( | |||
Commodity contracts .................... | ||||
Credit contracts .............................. | ( | ( | ( | ( |
Total ................................................. | $ | $ | $ | $( |
24 | Jefferies Financial Group Inc. |
OTC Derivative Assets (1) (2) (3) | |||||
$ in thousands | 0 – 12 Months | 1 – 5 Years | Greater Than 5 Years | Cross- Maturity Netting (4) | Total |
Commodity swaps, options and forwards ...................................... | $ | $ | $ | $ | $ |
Equity options and forwards .......... | ( | ||||
Credit default swaps ....................... | |||||
Total return swaps ........................... | ( | ||||
Foreign currency forwards, swaps and options ................................. | ( | ||||
Fixed income forwards ................... | |||||
Interest rate swaps, options and forwards ...................................... | ( | ||||
Total ................................................... | $ | $ | $ | $( | |
Cross-product counterparty netting .......................................... | ( | ||||
Total OTC derivative assets included in Financial instruments owned .................... | $ | ||||
OTC Derivative Liabilities (1) (2) (3) | |||||
$ in thousands | 0 – 12 Months | 1 – 5 Years | Greater Than 5 Years | Cross- Maturity Netting (4) | Total |
Commodity swaps, options and forwards ...................................... | $ | $ | $ | $ | $ |
Equity options and forwards .......... | ( | ||||
Credit default swaps ........................ | |||||
Total return swaps ........................... | ( | ||||
Foreign currency forwards, swaps and options ................................. | ( | ||||
Fixed income forwards ................... | |||||
Interest rate swaps, options and forwards ...................................... | ( | ||||
Total ................................................... | $ | $ | $ | $( | |
Cross-product counterparty netting .......................................... | ( | ||||
Total OTC derivative liabilities included in Financial instruments sold, not yet purchased ................................... | $ | ||||
Counterparty credit quality (1): | $ in thousands |
A- or higher ............................................................................................... | $ |
BBB- to BBB+ ........................................................................................... | |
BB+ or lower ............................................................................................. | |
Unrated ..................................................................................................... | |
Total .......................................................................................................... | $ |
August 31, 2025 | |||
External Credit Rating | |||
$ in millions | Investment Grade | Non- investment Grade | Total Notional |
Credit protection sold: | |||
Index credit default swaps ..................... | $ | $ | $ |
November 30, 2024 | |||
External Credit Rating | |||
$ in millions | Investment Grade | Non- investment Grade | Total Notional |
Credit protection sold: | |||
Index credit default swaps ..................... | $ | $ | $ |
$ in millions | August 31, 2025 | November 30, 2024 |
Derivative instrument liabilities with credit-risk- related contingent features .................................... | $ | $ |
Collateral posted ........................................................... | ( | ( |
Collateral received ........................................................ | ||
Return of and additional collateral required in the event of a credit rating downgrade below investment grade (1) ............................................... |
August 2025 Form 10-Q | 25 |
August 31, 2025 | ||||
$ in millions | Securities Lending Arrangements | Repurchase Agreements | Obligation to Return Securities Received as Collateral, at Fair Value | Total |
Collateral Pledged: | ||||
Corporate equity securities ..................... | $ | $ | $ | $ |
Corporate debt securities ..................... | ||||
Mortgage-backed and asset-backed securities ..................... | ||||
U.S. government and federal agency securities ..................... | ||||
Municipal securities ........ | ||||
Sovereign obligations ..... | ||||
Loans and other receivables .................. | ||||
Total .................................. | $ | $ | $ | $ |
November 30, 2024 | ||||
$ in millions | Securities Lending Arrangements | Repurchase Agreements | Obligation to Return Securities Received as Collateral, at Fair Value | Total |
Collateral Pledged: | ||||
Corporate equity securities ..................... | $ | $ | $ | $ |
Corporate debt securities ..................... | ||||
Mortgage-backed and asset-backed securities ..................... | ||||
U.S. government and federal agency securities ..................... | ||||
Municipal securities ........ | ||||
Sovereign obligations ..... | ||||
Loans and other receivables .................. | ||||
Total .................................. | $ | $ | $ | $ |
August 31, 2025 | |||||
$ in millions | Overnight and Continuous | Up to 30 Days | 31-90 Days | Greater than 90 Days | Total |
Securities lending arrangements .............. | $ | $ | $ | $ | $ |
Repurchase agreements . | |||||
Obligation to return securities received as collateral, at fair value ............................. | |||||
Total ................................... | $ | $ | $ | $ | $ |
November 30, 2024 | |||||
$ in millions | Overnight and Continuous | Up to 30 Days | 31-90 Days | Greater than 90 Days | Total |
Securities lending arrangements .............. | $ | $ | $ | $ | $ |
Repurchase agreements . | |||||
Obligation to return securities received as collateral, at fair value ............................. | |||||
Total ................................... | $ | $ | $ | $ | $ |
26 | Jefferies Financial Group Inc. |
August 31, 2025 | ||||||
$ in millions | Gross Amounts | Netting in Consolidated Statements of Financial Condition | Net Amounts in Consolidated Statements of Financial Condition | Additional Amounts Available for Setoff (1) | Available Collateral (2) | Net Amount (3) |
Assets: | ||||||
Securities borrowing arrangements ................................... | $ | $ | $ | $( | $( | $ |
Reverse repurchase agreements ......................................... | ( | ( | ( | |||
Securities received as collateral, at fair value ................... | — | — | ( | — | ||
Liabilities: | ||||||
Securities lending arrangements ........................................ | $ | $ | $ | $( | $( | $ |
Repurchase agreements ....................................................... | ( | ( | ( | |||
Obligation to return securities received as collateral, at fair value ............................................................................. | — | — | ( | — | ||
November 30, 2024 | ||||||
$ in millions | Gross Amounts | Netting in Consolidated Statements of Financial Condition | Net Amounts in Consolidated Statements of Financial Condition | Additional Amounts Available for Setoff (1) | Available Collateral (2) | Net Amount (4) |
Assets: | ||||||
Securities borrowing arrangements ................................... | $ | $ | $ | $( | $( | $ |
Reverse repurchase agreements ......................................... | ( | ( | ( | |||
Securities received as collateral, at fair value ................... | — | — | ( | — | ||
Liabilities: | ||||||
Securities lending arrangements ........................................ | $ | $ | $ | $( | $( | $ |
Repurchase agreements ....................................................... | ( | ( | ( | |||
Obligation to return securities received as collateral, at fair value ............................................................................. | — | — | ( | — | ||
August 2025 Form 10-Q | 27 |
$ in millions | August 31, 2025 | November 30, 2024 |
Cash and securities segregated and on deposit for regulatory purposes or deposited with clearing and depository organizations .................................................. | $ | $ |
Three Months Ended August 31, | Nine Months Ended August 31, | |||
$ in millions | 2025 | 2024 | 2025 | 2024 |
Transferred assets ..................... | $ | $ | $ | $ |
Proceeds on new securitizations ....................... | ||||
Cash flows received on retained interests .................. | ||||
$ in millions | August 31, 2025 | November 30, 2024 | ||
Securitization Type | Total Assets | Retained Interests | Total Assets | Retained Interests |
U.S. government agency RMBS ... | $ | $ | $ | $ |
U.S. government agency CMBS ... | ||||
CLOs ................................................. | ||||
Consumer and other loans ........... | ||||
28 | Jefferies Financial Group Inc. |
August 31, 2025 (1) | ||
$ in millions | Secured Funding Vehicles | Other |
Cash ................................................................................... | $ | $ |
Financial instruments owned ........................................ | ||
Securities purchased under agreements to resell (2) | ||
Receivables from brokers (3) ......................................... | ||
Other receivables ............................................................. | ||
Other assets (4) ............................................................... | ||
Total assets ...................................................................... | $ | $ |
Financial instruments sold, not yet purchased ........... | $ | $ |
Other secured financings (5) ......................................... | ||
Other liabilities (6) ........................................................... | ||
Long-term debt ................................................................ | ||
Total liabilities ................................................................. | $ | $ |
November 30, 2024 (1) | ||
$ in millions | Secured Funding Vehicles | Other |
Cash ................................................................................... | $ | $ |
Financial instruments owned ......................................... | ||
Securities purchased under agreements to resell (2) | ||
Receivables from brokers (3) ......................................... | ||
Other receivables ............................................................. | ||
Other assets (4) ............................................................... | ||
Total assets ...................................................................... | $ | $ |
Financial instruments sold, not yet purchased ........... | $ | $ |
Other secured financings (5) ......................................... | ||
Other liabilities (6) ........................................................... | ||
Long-term debt ................................................................ | ||
Total liabilities ................................................................. | $ | $ |
August 2025 Form 10-Q | 29 |
August 31, 2025 | ||||
Carrying Amount | Maximum Exposure to Loss | VIE Assets | ||